Overview

Evaluation of Effect of Renal Impairment on the PK of Tenofovir Exalidex

Status:
Completed
Trial end date:
2018-02-20
Target enrollment:
Participant gender:
Summary
This is a Phase 1 study to investigate the effects of Renal Impairment on the pharmacokinetics of Tenofovir exalidex
Phase:
Phase 1
Details
Lead Sponsor:
ContraVir Pharmaceuticals, Inc.
Treatments:
Tenofovir